Form D · Biotechnology
CASTLE BIOSCIENCES INC
Friendswood, TX · CIK 0001447362
Offering snapshot reported Jul 30, 2019 · SEC filing
- Reported sold
- $10M Offering amount: $20M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 12, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 30, 2019 | Initial | $10,000,000 | No comparison | 1 | SEC filing |
| Mar 21, 2019 | Amendment | $11,770,375 | $3,050,000vs Feb 14, 2019 | 65 | SEC filing |
| Feb 14, 2019 | Initial | $8,720,375 | No comparison | 63 | SEC filing |
| Jun 13, 2018 | Initial | $5,058,036 | No comparison | 44 | SEC filing |
| Jan 19, 2018 | Initial | $5,475,746 | No comparison | 48 | SEC filing |
| Jul 30, 2015 | Initial | $11,700,000 | No comparison | 17 | SEC filing |
| Aug 18, 2014 | Initial | $7,518,000 | No comparison | 4 | SEC filing |
| Aug 5, 2014 | Initial | $1,501,000 | No comparison | 4 | SEC filing |
| May 5, 2014 | Initial | $1,000,000 | No comparison | 3 | SEC filing |
| Nov 19, 2013 | Initial | $1,000,000 | No comparison | 3 | SEC filing |
| May 16, 2013 | Initial | $1,508,000 | No comparison | 7 | SEC filing |
| Oct 4, 2012 | Initial | $1,343,689 | No comparison | 10 | SEC filing |
| Mar 12, 2010 | Initial | $1,124,999 | No comparison | 6 | SEC filing |
| Mar 20, 2009 | Amendment | $860,900 | No comparison | Not reported | SEC filing |
| Mar 20, 2009 | Amendment | $935,899 | No comparison | Not reported | SEC filing |
| Oct 2, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-345302
Total Offering Amount includes amounts receivable upon exercise of warrants to purchase shares of Common Stock (assuming no net exercise, where applicable). The warrants have not yet been exercised.
Source: Form D, filed Jul 30, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Bonnie Anderson | Director |
| Mara Aspinall | Director |
| Daniel M. Bradbury | Director |
| G. Bradley Cole | Director |
| Joseph C. Cook, Iii | Director |
| Joseph C. Cook, Jr. | Director |
| Joe Cook, Jr. | Director |
| David Kabakoff, Ph.D. | Director |
| Garheng Kong | Director |
| Derek Maetzold | Director, Executive |
| Federico Monzon, M.D., Fcap | Executive |
| Bernhard E. Spiess | Executive |
| Frank Stokes | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
820 S Friendswood Drive Suite 201
Friendswood, TX, 77546
Friendswood, TX, 77546